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Abstract
Background: Pharmacological thrombolysis with streptokinase, urokinase or tissue activator of plasminogen (t-PA),
and mechanical interventions are frequently used in the treatment of both arterial and venous thrombotic diseases.
It has been previously reported that application of ultrasound as an adjunct to thrombolytic therapy offers unique
potential to improve effectiveness. However, little is known about effects of the ultrasound on proteins of blood
coagulation and fibrinolysis. Here, we investigated the effects of the ultrasound on fibrinogen on processes of
coagulation and fibrinogenolysis in an in vitro system.
Results: Our study demonstrated that low frequency high intensity pulse ultrasound (25.1 kHz, 48.4 W/cm2, duty
50%) induced denaturation of plasminogen and t-PA and fibrinogen aggregates formation in vitro. The aggregates
were characterized by the loss of clotting ability and a greater rate of plasminolysis than native fibrinogen. We
investigated the effect of the ultrasound on individual proteins. In case of plasminogen and t-PA, ultrasound led to
a decrease of the fibrinogenolysis rate, while it increased the fibrinogenolysis rate in case of fibrinogen. It has been
shown that upon ultrasound treatment of mixture fibrinogen or fibrin with plasminogen, t-PA, or both, the rate of
proteolytic digestion of fibrin(ogen) increases too. It has been shown that summary effect on the fibrin(ogen)
proteolytic degradation under the conditions for combined ultrasound treatment is determined exclusively by
effect on fibrin(ogen).
Conclusions: The data presented here suggest that among proteins of fibrinolytic systems, the fibrinogen is one of
the most sensitive proteins to the action of ultrasound. It has been shown in vitro that ultrasound induced
fibrinogen aggregates formation, characterized by the loss of clotting ability and a greater rate of plasminolysis
than native fibrinogen in different model systems and under different mode of ultrasound treatment. Under
ultrasound treatment of plasminogen and/or t-PA in the presence of fibrin(ogen) the stabilizing effect fibrin(ogen)
on given proteins was shown. On the other hand, an increase in the rate of fibrin(ogen) lysis was observed due to
both the change in the substrate structure and promoting of the protein-protein complexes formation.
Background
Thrombosis in the cardiovascular system is the one of
the leading causes of mortality and morbidity in the
world. Pharmacological thrombolysis using streptoki-
nase, urokinase or tissue activator of plasminogen (t-PA)
and mechanical interventions are frequently employed
to treat both arterial and venous thrombotic diseases.
Unfortunately, reperfusion is not always achieved and
t h es u c c e s so ft h et h e r a p yi slimited by reocclusion [1].
Limitations to these approaches also include complica-
tions such as bleeding, stroke, clot embolization and
vessel wall damage [2]. Increasing evidence from in vitro
[3-8], animal [9-11], and initial patients studies [12,13]
indicates that application of ultrasound (US) as an
adjunct to thrombolytic therapy offers unique potential
to improve effectiveness and decrease bleeding compli-
cations. Now, four basic approaches to US thrombolysis
have been pursued - two without pharmacological
agents: (1) catheter-delivered external transducer US, (2)
transcutaneous-delivered HIFU external US without
drug delivery and US in conjunction with thrombolytic
drugs and/or microbubbles or other agents, (3) catheter-
delivered transducer-tipped US with local drug delivery,
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concomitant systemic (intravenous) drug delivery for
site specific US augmentation [14]. Based on the avail-
able information the mechanisms involved in the fibri-
nolytic process in high-frequency, low-intensity US-
enhanced fibrinolysis have been suggested [15] to be
non drug-specific [16], not to alter the sizes of plasmatic
derivatives or degradation products [17] and not to be
caused by clot disruption [16]. US with a frequency of 1
MHz and intensities of 2.5-3.1 W/cm
2 had no statisti-
cally significant impact on biological activity of plasmi-
nogen activators: urokinase, streptokinase, alteplase and
reteplase [18]. There is a limited data on the potential
effect of US on proteins. It has been shown that high
frequency (1 MHz) US with intensity of 6.92 W/cm
2
caused changes in structural order of cytochrome c,
lysozyme, myoglobin, bovine serum albumin, trypsino-
gen and a-chymotrypsinogen A [19]. At low intensity
US accelerates enzymatic thrombolysis through non-
thermal mechanisms involving improvement in drug
transport [8,20], reversibly altering fibrin structure [1,20]
and increasing t-PA binding to fibrin [1]. Recent studies
indicated that US at lower frequencies in the range of
20-40 kHz and impulse mode with duty cycles of 1 to
50% has a greater effect on thrombolysis with improved
tissue penetration and less heating [1,11,21]. High inten-
sity US disrupts clots into small fragments without
administration of plasminogen activator [1,13]. The
main mechanism by which ultrasonic lysis of thrombus
occurs is termed the “cavitation effect.” During the
negative phase of the ultrasonic wave, microbubbles (or
cavities) form within tissue exposed to the sound source.
During the positive phase of the wave, these cavitations
collapse, giving rise to a series of shock waves that lead
to disruption and fragmentation. However, despite the
documented efficiency, further clinical application of US
angioplasty is restricted by the initiation of distal embo-
lization of the resulting clot debris [14]. Our previously
study demonstrated that at the conditions of a com-
bined cavitation and streptokinase action at high US
intensities, streptokinase preventing the formation of
large clot debris conglomerates [22]. Based on this, we
assume that the use of low frequency (20-40 kHz)
impulse (duty cycle 1-50%) mild intensity (10-50 W/
cm
2) US in combination with thrombolytic drugs will
make it possible to decrease the risk of side effects
development. The effectiveness of this approach has
been confirmed by our in animal study [23].
With a number of described above mechanisms of US
thrombus destruction and US enhanced fibrinolysis
additional mechanisms may underlie the effects of US
thrombolysis Analyses of the products of the plasma
clot destruction by the low-frequency ultrasound (27
kHz) showed that at the US intensities below 21.6 W/
cm
2, there was extraction of blood serum proteins
located in the pores of the fibrin network. The increase
in intensity of the ultrasonic treatment was accompanied
by protofibrils disaggregation and extraction of blood
serum proteins located inside fibrin fibers. Proteins
extracted from the plasma clot underwent subsequent
aggregation, whereas interaction between protofibrils
caused formation of insoluble fibrin particles [24]. Thus,
low frequency and high intensity ultrasound together
with the macroscopic disruption of the clot can affect
structural-functional properties of proteins.
It has been previously shown that usage of low fre-
quency US (26 kHz) with intensity up to 15 W/cm
2
does not influence properties of streptokinase and
antithrombin III. At US intensity exceeding 26 W/cm
2,
plasminogen activator streptokinase undergoes irreversi-
ble aggregation with unfolding of protein molecule and
exposure of new peptide bonds susceptible for proteoly-
tic attack by plasmin [25]. After US treatment, antith-
rombin III is converted into inactive forms (latent and
polymeric aggregates), whereas non-activated blood clot-
ting factors belonging to the a-chymotrypsin superfam-
ily do not change their structural and functional
parameters within PPSB complex [26]. At the same
time, a functional model of activation of equimolar mix-
ture of a-chymotrypsinogen and trypsinogen revealed
that trypsin is the most sensitive to the US treatment
[27].
The aim of current studies was to investigate the
effects of low frequency high intensity pulse US (25.1
kHz, 48.4 W/cm2, duty 50%) on the key protein of the
blood coagulation - fibrinogen, as well as to investigate
the effects of US on the fibrinolysis in an in vitro system.
It has been shown that ultrasound induced time-depen-
dent formation of fibrinogen aggregates, characterized
by loss of clotting ability and greater rate of plasminoly-
sis than native fibrinogen and denaturation of plasmino-
gen and t-PA. Under ultrasound treatment of
plasminogen and/or t-PA in the presence of fibrin
(ogen), the stabilizing effect of fibrin(ogen) on given
proteins was demonstrated. On the other hand, an
increase in the rate of fibrin(ogen) lysis was observed
due to both the change in the substrate structure and
promoting of the protein-protein complexes formation.
Studies in this direction are address the key question
how to minimize side effects and increase the effective-
ness of ultrasonic trombolysis.
Methods
Materials
The following reagents were used in this study: SDS, 2-
mercaptoethanol, Coomassie Brilliant Blue G-250, tris-
(hydroxymethyl)aminomethane, N, N, N’,N ’-t e t r a -
methylenediamine, glycine, ammonium persulfate
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teases ("Roche”, Germany), N.N’-methylene-bis-acryla-
mide, ("Reanal”, Hungary); the collection of protein
standards for the gel-electrophoresis (phosphorylase B
(97.4 kDa), bovine serum albumin (67 kDa), ovalbumin
(45 kDa), carboanhydrase (29 kDa)) ("Serva”,G e r m a n y ) ;
Lysine-Sepharose were obtained by the immobilization
of lysine to epichlorohydrin-activated Sepharose-4B CL
[28].
The t-PA was obtained from the manufacturer
(recombinant t-PA, Actilyse, “Boehringer Ingelheim”,
Germany) was dissolved in 0.05 M Tris-HCl, 0.15 M
NaCl (pH 7.4) to give a final concentration of 10 mg/ml
and stored at -20°C. This solution was used for the acti-
vation of plasminogen preparations.
Bovine fibrinogen, 97% clottable, was prepared the
method of Blomback and Blomback [29] from fresh fro-
zen citrate plasma. Plasminogen was purified by affinity
chromatography on lysine-Sepharose from fresh frozen
citrated bovine plasma according to Deutsch et al. [30].
Ultrasound source
The thrombolytic device “Pulsar” developed at the Belar-
usian State Polytechnic Academy (Minsk, Belarus) was
used as a source of US. It consists of an US generator, a
piezoelectric converter of the US oscillations, and a flex-
ible 0.8 mm ball-tipped wire. The diameter of the emit-
ting working surface is 0.6 mm with a length of 245
mm. The power output of generator is 80 W. The
power output at the acoustic horn was 48.4 W/cm
2 with
a 50% duty cycle of 0.9 sec on and 0.9 sec off and a fre-
quency of 25.1 kHz.
The protein was dissolved in 0.05 M Tris-HCl buffer
at pH 7.4, containing 0.15 M NaCl. The sample solution
in a polypropylene tube was placed in a water bath at
37°C. The US wire was loaded in sample solution at a
depth of 1 cm. During US treatment, temperature
increase did not exceed 0.5°C.
Gel-permeation chromatography
Chromatography was carried out on an automatic Gra-
diFrac (Pharmacia Biotech) system including a pro-
grammed fraction collector, a flow UV-detector (l =
280 nm), a gradient mixer, and a peristaltic pump. A
Sepharose 4B-CL column (10 × 950 mm) was used. The
buffer containing 0.05 M Tris-HCl at pH 7.4 and 0.15
M sodium chloride was used to equilibrate the column.
Different fibrinogen species were eluted at a flow rate
0.1 ml/min.
SDS-PAGE
Electrophoresis in 10% and 7.5% polyacrylamide with
and without reduction with 5% (v/v) 2-mercaptoethanol
was performed as described by Laemmli [31]. Protein
b a n d sw e r ev i s u a l i z e dw i t hC o o m a s s i eB l u es t a i n i n g .
The calculation of the molecular weights of bands and
densitograms were constructed with using “Phoretix 1D”
software (Nonlinear Dynamics Ltd, United States)
Scanning electron microscopy
Clots obtained after the US treatment were fixed, dehy-
drated, dried and covered with an electrically conducting
15- 20 nm thick golden layer [22]. The photomicrograph
was obtained by means of a Nanolab-7 scanning elec-
tron microscope using an accelerating voltage of 20 kV
at magnifications of 1000×, 2500×, 5000× and 10000×.
Turbidity measurements
Polymerization at the ambient temperature was moni-
tored continuously at 350 nm in a spectrophotometer
UV-1202 (Shimadzu Corporation, Tokyo, Japan). The
reaction was initiated by addition of 300 μlt h r o m b i na t
a concentration from 25 unit/ml to 3 ml fibrinogen
solution (3 mg/ml) in 0.05 M Tris-HCl, pH 7.4, contain-
ing 0.15 M sodium chloride.
Fibrinogenolysis
Fibrinogenolysis was carried out in 0.05 M Na-phos-
phate buffer, containing 0.15 M NaCl at pH 7.4. Proteo-
lysis was initiated by addition of 150 μl of plasminogen
(2 mg/ml) and t-PA (0.2 mg/ml) to 15 ml of the solu-
tion of fibrinogen (3 mg/ml). The digestion mixture was
then incubated at 37°C and samples were collected after
certain time intervals for SDS-PAGE and determination
of TCA-soluble peptide analysis.
Fibrinolysis
Clot preparation
The fibrin clot was prepared by an addition of 300 μlo f
1 M CaCl2 and 1.5 ml of thrombin solution (25 unit/ml
in 0.05 M Tris-HCl, 0.5 M NaCl at pH 7.4) to 15 ml
fibrinogen solution (3 mg/ml in the same buffer). The
final mixture was incubated for 2 hour at 37°C. The
resultant clot was dried between the two sheets of the
filter paper.
Clot lysis
The clot was placed in the polypropylene tube with buf-
fer, containing 15 ml 0.05 M Tris-HCl and 0.5 M NaCl
at pH 7.4. For the initiation of the fibrinolysis 150 μlo f
the plasminogen solution (1.5 mg/ml in 0,025 M Tris-
HCl, 50% glycerol, pH 7,4) and 150 μl rt-PA (10 mg/ml
in 0.05 M Tris-HCl, 0.5 M NaCl (pH 7.4)) were added
to the mixture. The mixture was incubated at 37°C and
during 4 hours of hydrolysis the samples were collected.
The aliquots were used for SDS-PAGE (a mixture for
protein denaturation with or without 2-mercaptoethanol
was directly added to these aliquots) and the determina-
tion of TCA-soluble peptide.
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To 1.5 ml analyzable sample 1.0 ml 15% TCA were
added. Samples centrifuged (8000 × g, 5 min) and the
optical density of solution at 280 nm was measured.
The concentration of the TCA-dissoluble peptide they
recounted to the appropriate concentration of tyrosine




=D 280nm · 2.5/1.15
Statistical analysis
Statistical analysis was carried out employed the Micro-
soft Excel 2000 software. Results were tested by the Stu-
dent’s t test. Data expressed as mean +/- standard
deviation. A p value ≤ 0.05 was considered to be statisti-
cally significant.
Results
Fibrinogen was exposed to ultrasound for 30 minutes at
37°C and then assayed by SDS-PAGE under reducing
and nonreducing conditions (Figure 1). Gel-electrophor-
esis without reduction of inter- and intramolecular dis-
ulfide bonds showed presence of one polypeptide with
the molecular weight of more than 250 kDa (band on
the top of the gel) in the US-treated and the control
samples. The same samples separated on the SDS-PAGE
gel containing b-mercaptoethanol showed three identical
polypeptides corresponding to native Aa-, Bb-, and g-
chains of fibrinogen (Figure 1).
The effects of the US on functional activity of the
fibrinogen were investigated. For this purpose, two phy-
siologically important processes involving fibrinogen
were tested: the formation of a fibrinogen clot and fibri-
nogenolysis. The clotting ability was tested by adding
thrombin and measuring the increase in turbidity at 350
nm. For the control sample of fibrinogen, exponential
increase of the turbidity with an increase of incubation
time was observed (Figure 2, line 1). The initial velocity
and the stationary level of the absorption decreased for
the sample treatment ultrasound during 5 min (Figure
2, line 2). A sonication of 30 minutes led to the total
loss of the clotting ability (Figure 2, line 3).
The electrophoretic pattern of the fibrinogen proteoly-
tic degradation products by plasmin after treatment
with b-mercaptoethanol is shown in Figure 3. Identical
distribution of polypeptide bands for both sonicated and
control fibrinogen samples were observed. At zero time
of proteolysis, three polypeptides corresponding to Aa-,
Bb-, and g-chains of fibrinogen were present. The
decrease of the content of the native chains and respec-
tively the accumulation of proteolytically modified b’’-,
g’-, g’’-a n dg’’’- chains of fibrinogen were observed dur-
ing the time course of the fibr i n o g e ni n c u b a t i o nw i t h
plasminogen and t-PA (Figure 3).
Figure 4 shows the results of fibrinogen gel-permea-
tion chromatography before and after sonication. There
are two peaks on the chromatogram of native fibrino-
gen. First dominant peak is native fibrinogen (MW 340
kDa), while second one corresponds to proteins with
Figure 1 SDS-PAGE analysis of fibrinogen samples. 1 - sonicated
(25.1 kHz, 48.4 W/cm2, duty 50%) at 37°C for 30 min; 2 - control
(treated at 37°C for 30 min) samples of fibrinogen (Fg) in the
presence (+bME) and absence (-bME) b-mercaptoethanol. Aa,B b, g
- corresponding native fibrinogen chains.
Figure 2 Clotting of fibrinogen.n a t i v e( 1) and US-treated (25.1
kHz, 48.4 W/cm2, duty 50%) during 5 (2) and 30 (3) min fibrinogen.
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matogram with the US-treated fibrinogen sample, there
are two peaks corresponding to proteins with MW >
600 kDa (Figure 4, line 2). The increase in the molecular
weight of proteins occurs due to the formation of aggre-
gates, since the US does not induce the formation of
covalent cross-links as demonstrated above.
Next, the influence of the low-frequency US on the
proteolytic degradation of fibrinogen in the fibrinogen:
plasminogen: t-PA system was investigated. The fibrino-
genolysis rate was estimated by determining the concen-
tration of TCA-soluble peptide released during proteins
incubation at 37°C. Figure 5 shows that US has differen-
tial effects on individual proteins. The US treatment led
to increase of fibrinogenolysis rate in case of fibrinogen
(Figure 5, line 2), while it decreased fibrinogenolysis in
case of plasminogen (Figure 5, line 3) and t- PA (Figure
5, line 4) in comparison to control (Figure 5, line 1).
Figure 6 shows that the beforehand incubation of plas-
minogen with t- PA (Figure 6, line 2) for 30 min led to
increase in the fibrinogenolysis rate in comparison with
the control experiment (Figure 6, line 1). Obviously, in
this case a larger quantity of already formed active plas-
min was added to fibrinogen. In turn, beforehand US
treatment of the mixture of plasminogen with t-PA
leads to considerable reduction in the fibrinogenolysis
rate (Figure 6, line 5). Moreover, this effect was not the
sum of the inactivating actions of ultrasound on t-PA
(Figure 6, line 3) and plasminogen (Figure 6, line 4), but
was taken intermediate value.
The influence of ultrasound on the rate of the enzy-
matic hydrolysis of fibrinogen in the fibrinogen: plasmi-
nogen: t-PA system was investigated upon introduction
of the plasminogen activator after the US treatment. Fig-
ure 7 presents data analysis of reducing and non-redu-
cing samples of fibrinogen proteolysis products. Time-
Figure 3 Densitograms of SDS-PAGE analysis of fibrinogen proteolysis products in the presence of b-mercaptoethanol. A - native and
B - sonicated (25.1 kHz, 48.4 W/cm2, duty 50%,) at 37°C during 15 min fibrinogen, after 15 min (1) and 5 hours (2) after addition mixture of
plasminogen with rt-PA. Aa,B b, b’, b’’, g, g’, g’’ - corresponding chains of fibrinogen.
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tide chain (Aa,B b and g) and accordingly the accumula-
tion of the end products of the fibrinogen plasminolysis
-f r a g m e n t sD 1,D 2,D 3 through the intermediate forma-
tion of the partially degraded fragments X and Y
occurred independently of the US treatment. However,
the electrophoregrams of the not reducing control sam-
ple after 1 hour of the hydrolysis (Figure 7A, right col-
umn, line 5) show the presence of only early fibrinogen
degradation product - fragment X. At the same time, in
the case of preliminary sonication of fibrinogen with
plasminogen approximately half of all fibrinogen is con-
verted into the fragments Y and D (Figure 7B, right col-
umn, line 5).
The following part concerns the investigation of the
influence of ultrasound on fibrinogenolysis with the US
treatment of all three proteins (Figure 8). It is evident
that in the case of combined US-treatment (Figure 8,
line 3), an increase of fibrinogenolysis rate occurs as in
case of fibrinogen.
For the investigation of US effects on fibrinolysis, the
model of fibrin clot, prepared by coagulation of pure
fibrinogen by thrombin in presence of Ca
2+ ions, was
used. Initial fibrinogen contained sufficient quantity of
factor XIII for complete covalent cross-linking of fibrin
monomers. Plasminolysis was initiated by addition of
the plasminogen and t-PA to the fibrinogen solution.
Figure 4 Gel-permeation chromatography of fibrinogen
samples. 1 - native; 2 - US-treatment (25.1 kHz, 48.4 W/cm2, duty
50%,) during 30 min. Column: Sepharose-4B CL (950 × 16 mm),
buffer 0,05 M Na-phosphate, 0,15 M NaCl, pH 7,4, rate 0,1 ml/min,
detection 280 nm. I-fibrinogen, II-fibrinogen aggregates.
Figure 5 Proteolytic degradation of fibrinogen by the mixture
of plasminogen and rt-PA under different modes of US-
treatment. 1 - control (without US action); 2 - sonicated during 30
min fibrinogen; 3 - sonicated during 30 min plasminogen; 4 -
sonicated during 30 min rt-PA. Ultrasound: 25.1 kHz, 48.4 W/cm2,
duty 50%. Data represent mean +/-SD of three independent
experiments.
Figure 6 Proteolytic degradation of fibrinogen by the mixture
of plasminogen and rt-PA under different modes of US-
treatment. 1-control; 2- prior incubation rt-PA with plasminogen at
37°C during 30 min; 3- sonicated during 30 min plasminogen; 4-
sonicated during 30 min t-PA; 5 -prior US-treatment mixture of
plasminogen with t-PA. Ultrasound: 25.1 kHz, 48.4 W/cm2, duty 50%.
Data represent mean +/-SD of three independent experiments.
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Page 6 of 11The process of the fibrinolysis, like fibrinogenolysis, was
controlled by the determination of the concentration of
TCA-soluble peptide formation. As in the case of fibri-
nogen, US-treatment leads to the increased rate of pro-
teolysis in both cases, after treating the clot itself and
clot in the presence of plasminogen and/or rt-PA. SDS-
PAGE of fibrin degradation products revealed that
already after 2 hour of hydrolysis mainly D-dimers were
present. At the same time, in the degradation products
of previously US-treated fibrin parallel with D-dimers
early fibrin degradation products - fragments X and Y
were present (data not shown). Analysis by the scanning
electron microscopy (Figure 9) showed that clot revealed
many deepening of 4 - 10 μm in size as a result of the
Figure 7 Gel- electrophoresis of the fibrinogen degradation products in the model systems. A - fibrinogen:plasminogen:t-PA, B -
preliminary US treatment (25.1 kHz, 48.4 W/cm2, duty 50%) mixture of fibrinogen with plasminogen during 15 min. with the subsequent
addition of rt-PA. 1,2,3,4,5,6,7 - 0,5,15,30,60 min, 5 h, 24 h of hydrolysis, respectively; 8 - standards. b-M E-b - mercaptoethanol. Fg, Fg-X, Fg-Y,
Fg-D1, Fg-D2, Fg-D3 are fibrinogen and products of its proteolytic degradation, respectively. Aa,B b, b’, b’’, g, g’, g’’ - corresponding chains of
fibrinogen. PhB - phosphorylase B, BSA - bovine serum albumin, Ov - ovalbumin, CA - carboanhydrase.
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internal structure of the clot showed that multiple chan-
nels appeared near the clot surface. These channels
were 1-2 μm in diameter, and 20-45 μm in length (Fig-
ure 9. c). Changes were also observed in the fibrin net-
work that acquired fine-mesh shape due to mach
irregular disruptions of fibers (Figure 9. d). The quanti-
tative analysis of the image showed substantial changes
in parameters of the US-treated fibrin network com-
pared to control. The ultrasound caused decrease of
length and diameter of fibrin fibers, but at the same
time increase in pore size.
Discussion
T h i ss t u d yd e m o n s t r a t e dt h a tt h eU Sd i dn o tc a u s et h e
cleavage of peptide and interchain disulfide bonds or for-
mation of interchain and intermolecular cross-links in
case of fibrinogen (Figure 1). Additionally, results pre-
sented here suggested that the US did not induce the con-
formational changes in the fibrinogen molecule leading to
the exposure of a new plasmin-sensitive site (Figure 3).
Our results are consistent with previously reported data
describing the effect of high-frequency US on fibrinogen
[16] and fibrin clot [17]. However, sonication of fibrinogen
with the US (25.1 kHz, 48.4 W/cm2, duty 50%) led to the
time-dependent loss of the clotting ability (Figure 2). It
has been reported that the g- irradiation and free-radical
oxidation leads to a loss of the clotting ability and increase
of the sensitivity to the proteolytic degradation as a result
of the fibrinogen aggregate formation [32]. To determine
if the US induced aggregation of fibrinogen, the gel-per-
meation chromatography of fibrinogen was carried out
before and after the sonication (Figure 4). The results of
gel-permeation chromatography indicated that the forma-
tion of fibrinogen aggregates was induced by the US. It
has been shown before that aggregation of antithrombin
III and streptokinase was also induced by the US [25,26].
Our study demonstrated that the US differentially
affected individual proteins and led in case of fibrinogen
(Figure 5, line 2) to increase, and in case of plasminogen
(Figure 5, line 3) and t-PA (Figure 5, line 4) to decrease
of fibrinogenolysis rate. It should be noted that no
change in the speed of the fibrinogen hydrolysis was
observed using the high-frequency US [16].
It is known that in the presence of fibrinogen, fibrin
and their degradation products, the rate of plasminogen
activation by t-PA increases due to the formation of ter-
tiary complex: fibrin(ogen) - plasminogen - t-PA [33]. In
this case, fibrin potentiates at greater extent an activa-
tion rate at the expense of the exposure of the plasmi-
nogen and t-PA binding sites that are latent in the
fibrinogen molecule. It has been reported that the
removal of fibrinopeptides A and B switches interaction
of aC-domain from intra- to intermolecular interaction,
facilitating the self-association of fibrin [34]. In this
regard, the conformational changes occur, which led to
the exposure of the plasminogen and t- PA binding sites
on the aC-domain surface. At the same time, D-region
also contains latent t-PA and the plasminogen binding
sites. The exposure of these sites is a result of the non-
covalent binding D-D:E [34]. As demonstrated above,
US led to the formation of fibrinogen associates with
the larger molecular weight. Therefore, it is possible to
suggest that the US produces conformational changes in
the fibrinogen molecule leading to the exposure of poly-
merization sites and, as a result, of the plasminogen-
and t-PA binding sites. These processes lead to an
increase in the rate of the proteolytic degradation of
fibrinogen. In turn, a decrease in the fibrinogenolysis
rate in cases of prior sonication of plasminogen and t-
PA is the result of inactivation of the active forms of
these proteins, as it was demonstrated above. The effect
of US inactivation enzymes was shown on example of
functional model of activation of equimolar mixture of
a-chymotrypsinogen and trypsinogen [27]. High sensi-
tivity of t-PA to the US-action is explained by the
unique structure of this protein. In comparison with
other proenzymes, the single-chain tissue-type plasmino-
gen activator possesses its own catalytic activity. More-
over, the activities of the single- and two-chain t-PA
differ only by a factor of 3-9. Existing evidence strongly
suggests that Lys
156 and Asp
194 interact directly in sin-
gle-chain t-PA and that this interaction stabilizes the
active conformation of the enzyme [33].
The obtained results suggest that the preliminary US-
treatment of the mixture of fibrinogen with plasminogen
Figure 8 Proteolytic degradation of fibrinogen by the mixture
of plasminogen and rt-PA under different modes of US-
treatment. US - 25.1 kHz, 48.4 W/cm
2, duty 50%. 1-control; 2-
sonicated during 30 min fibrinogen; 3- US-treatment mixture of
fibrinogen, plasminogen and rt-PA. Data represent mean +/-SD of
three independent experiments.
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case of sonicated plasminogen, but to its increase. The
US-treatment of the mixture of fibrinogen with plasmi-
nogen, most probably, does not cause any changes in
plasminogen, and summary effect is caused by the
action on the fibrinogen. It may be assumed that the
basic effect of the US on the proteins is caused by the
generation of free hydroxyl radicals in the field of US
cavitation. Thus, under the condition fibrinogen can act
as the “scavenger” of free radicals and, correspondingly,
summary effect on the fibrinogen proteolytic degrada-
tion for combined US-treatment is determined exclu-
sively by effect on fibrinogen. It is consistent with the
fact that fibrinogen appears to be a plasma protein that
is most sensitive to in vitro metal-ion-catalyzed carbonyl
formation [35]. During structural effect induced by ther-
apeutic ultrasound on aqueous solution of six different
proteins (cytochrome c, lysozyme, myoglobin, bovine
serum albumin, trypsinogen and a-chymotrypsinogen
A) important role of free radicals, produced by water
sonolysis, in the changes of structural order was suggest
too [19].
Statistical analysis showed the absence of differences in
the kinetic curves of fibrinogenolysis in the following cases
of US-treatment: a)f i b r i n o g e n ;b) fibrinogen with rt-PA;
c) fibrinogen with plasminogen and d) fibrinogen, plasmi-
nogen and rt-PA (Figure 8). Thus, in case of US-treatment
of the protein mixtures effect US on the fibrinogen proteo-
lytic degradation is determined exclusively by effect on
fibrinogen. The same results were obtained in the study of
the influence of US-processing on the fibrinolysis.
It has been shown before that the US-treatment leads
to an increase in the binding t-PA with fibrin [36]. By
the scanning electron microscopy showed changes of
Figure 9 Images of control (a, b)a n dU S - t r e a t e d( c, d) fibrin clot obtained by scanning electron microscopy at different
magnifications.
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Page 9 of 11the fibrin network in the process of US-treatment. Data
showed that US leads to formation of many channels in
the internal structure of the clot, and irregular disrup-
tion and thinning of fibrin fibers at the level of fibrin
network structure are observed (Figure 9). It has been
demonstrated earlier that disturbances of the fibrin net-
w o r ku n d e rt h eU S - a c t i o nl e a dt oa ni n c r e a s ei nt h e
penetration of t-PA inside the clot [16]. Due to the
increased number of plasminogen/plasmin binding sites,
the rate of proteolysis was increased. Obtained data well
agree with the layer-by-layer model of the fibrin degra-
dation, in the case of the penetration of the plasminogen
activator inside the clot due to the diffusion [37]. Thus,
in the control experiment the step-by-step hydrolysis of
fibrin was occurred and the large fragments of fibrin
were not released into the solution. At US-treatment of
fibrin, the proteolysis took place in entire volume of clot
and, respectively, the large fragments were released into
solution. This is confirmed by the fact that after two
h o u r so fh y d r o l y s i si nt h ed e g r a d a t i o np r o d u c t so fp r e -
viously US-treated fibrin parallel with D-dimers early
fibrin degradation products - fragments X and Y were
present, there are not in control. The same differences
were observed also at the fibrin clot lysis, induced by
circulating and clot-embedded proteases [38].
In summary, under ultrasound treatment of plasmino-
gen and/or t-PA in the presence of fibrin(ogen), the sta-
bilizing effect fibrin(ogen) on given proteins was shown,
while an increase in the fibrin(ogen)lysis rate was
demonstrated due to both the change in the substrate
structure and promoting of the protein-protein com-
plexes formation. This allows us to recommend for the
in vivo experiments simultaneous introduction of plas-
minogen activators with the US action and limiting
duration of US action by the not more than 5 min.
Conclusions
Our study demonstrated that the US induces fibrinogen
aggregate formation in vitro, characterized by loss of
clotting ability and greater rate of plasminolysis than
native fibrinogen. In case of the US treatment of mix-
ture fibrinogen or fibrin clot with plasminogen, t-PA or
both, the rate of proteolytic digestive of fibrin(ogen)
increase too, in this case fibrin(ogen) show stabilization
effect on plasminogen and t-PA.
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